Sales & Marketing News | pharmaphorum

News

Corcept shares surge on FDA approval of Lifyorli, a first-in-class selective glucocorticoid receptor antagonist for ovarian cancer.

News

Denali's Avlayah is the first drug for neurological complications associated Hunter syndrome to be approved in the US.

News

Shares in Anavex Life Sciences lost more than a third of their value today after the company abandoned an EU filing for its Alzheimer's therapy.

News

The FDA has sent a warning letter to ImmunityBio over "false and misleading" comments made by executive chair, billionaire Patrick Soon-Shiong.

News

Spanish plasma medicine specialist Grifols is planning to sell a minority stake in its US business, via an IPO, to help pay down its debt.

News

A cancer patient in the US has filed a class action lawsuit against Novartis in the US, claiming that the company shared her private health data.